A case of Conradi-Hünermann-Happle syndrome treated with topical simvastatin-cholesterol ointment

Jean Zevallos1, Stephanie Susano1

  • 1Dermatology Service, Department of Medicine, Hospital Maria Auxiliadora, Lima, Peru.

Pediatric Dermatology
|August 21, 2024
PubMed

Insights

Conradi-Hünermann-Happle syndrome, a rare genetic skin disorder affecting cholesterol metabolism, presents unique cutaneous findings. This case report explores treatment with a novel simvastatin-cholesterol ointment.

Area of Science:

  • Dermatology
  • Genetics
  • Metabolic Disorders

Background:

  • Conradi-Hünermann-Happle syndrome (CHHS) is a rare genodermatosis.
  • It is caused by pathogenic variants in the emopamil binding protein (EBP) gene.
  • CHHS affects cholesterol metabolism and presents with multi-systemic alterations.

Observation:

  • Patients exhibit characteristic cutaneous findings, including hyperkeratotic lesions along Blaschko lines.
  • These lesions can lead to scarring alopecia and atrophic patches.
  • Skeletal and ophthalmological abnormalities are also associated with the syndrome.

Findings:

  • This case report details a patient diagnosed with CHHS.
  • The patient was treated with a topical simvastatin-cholesterol ointment.
  • Treatment outcomes and clinical response were observed.

Implications:

  • This case may offer insights into novel therapeutic strategies for CHHS.
  • Targeting cholesterol metabolism topically could be a potential treatment avenue.
  • Further research is warranted to evaluate the efficacy and safety of simvastatin-cholesterol ointment in CHHS patients.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
601
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
78
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
413
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
454
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
98
Cholinergic Antagonists: Pharmacokinetics01:24

Cholinergic Antagonists: Pharmacokinetics

Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations,  while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
423